Literature DB >> 1772604

Stereotactic biopsy of cerebral lesions in patients with AIDS.

M F Pell1, D G Thomas, I R Whittle.   

Abstract

Central nervous system involvement with AIDS is not uncommon. The indications and timing of brain biopsy remains controversial. Stereotactic CT-guided biopsy offers a safe and effective means of establishing a diagnosis in any patient with a cerebral mass lesion and has less morbidity and mortality than freehand biopsy or exploratory craniotomy. Eleven patients with AIDS have undergone CT-directed stereotactic biopsy between May 1987 and November 1990 with one death from intracerebral haemorrhage. Histological diagnosis of the biopsy specimens showed multifocal leucoencephalopathy, toxoplasmosis, lymphoma and non-specific changes. Biopsy is recommended for patients with an atypical presentation, negative serology, progressive clinical deterioration and differential response of lesions to empirical therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1772604     DOI: 10.3109/02688699109002881

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

1.  Diagnostic value of stereotactic biopsy of cerebral lesions in patients with AIDS.

Authors:  F Alesch; C Armbruster; H Budka
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Brain biopsy in AIDS. Diagnostic value and consequence.

Authors:  C J Nielsen; F Gjerris; H Pedersen; F K Jensen; P Wagn
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

3.  Brain biopsy in AIDS patients: diagnostic yield and treatment applications.

Authors:  Zion Zibly; Itzchak Levy; Vlady Litchevski; Dvora Nass; Chen Hofmann; Jacob Barham; Christian A Graves; Roberto Spiegelmann; Moshe Hadani; Zvi R Cohen
Journal:  AIDS Res Ther       Date:  2014-01-21       Impact factor: 2.250

4.  Application of stereotactic biopsy for diagnosing intracranial lesions in patients with AIDS in China: Report of 7 cases.

Authors:  Ji-Bo Zhang; Kai Fu; Rui Gong; Xue-Meng Liu; Li-Dao Chen; Yong-Xi Zhang; Gui-Fang Yang; Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.